Alignment with FDA on Best Corrected Visual Acuity ? 15-Letter Loss as Primary Outcome Measure - Representing the Highest Value Outcome to Patients and Physicians

Excerpt from:
Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint